Methadone for Opioid Use Disorder-Decades of Effectiveness but Still Miles Away in the US.
作者信息
Joudrey Paul J, Edelman E Jennifer, Wang Emily A
机构信息
Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
出版信息
JAMA Psychiatry. 2020 Nov 1;77(11):1105-1106. doi: 10.1001/jamapsychiatry.2020.1511.
Abstract
摘要
相似文献
1
Methadone for Opioid Use Disorder-Decades of Effectiveness but Still Miles Away in the US.美沙酮用于阿片类物质使用障碍——数十年成效显著，但在美国仍任重道远。
JAMA Psychiatry. 2020 Nov 1;77(11):1105-1106. doi: 10.1001/jamapsychiatry.2020.1511.
2
Use and misuse of opioid agonists in opioid addiction.阿片类药物成瘾中阿片类激动剂的使用和滥用。
Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.
3
Methadone is no panacea.美沙酮并非万灵药。
BMJ. 2012 Aug 22;345:e5670. doi: 10.1136/bmj.e5670.
4
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.关于：丁丙诺啡和美沙酮维持治疗在孕期的疗效与效果的评论
J Addict Dis. 2012;31(4):321-6; discussion 327-8. doi: 10.1080/10550887.2012.736289.
5
Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.丁丙诺啡和美沙酮维持疗法在孕期的疗效与效果对比
J Addict Dis. 2011 Oct;30(4):318-22. doi: 10.1080/10550887.2011.609806.
6
The development of Methadone Maintenance Treatment in the Maldives.马尔代夫美沙酮维持治疗的发展
Int J Drug Policy. 2013 Mar;24(2):164-5. doi: 10.1016/j.drugpo.2012.07.003. Epub 2012 Aug 9.
7
Methadone and buprenorphine during pregnancy.孕期美沙酮和丁丙诺啡。
J Addict Med. 2015 May-Jun;9(3):252. doi: 10.1097/ADM.0000000000000135.
8
Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.初级保健中青少年阿片类物质使用障碍的药物治疗
Pediatr Rev. 2018 Jan;39(1):43-45. doi: 10.1542/pir.2017-0153.
9
Overview of Drugs Used to Treat Opioid Use Disorder.用于治疗阿片类物质使用障碍的药物概述。
Am J Nurs. 2018 Aug;118(8):25. doi: 10.1097/01.NAJ.0000544161.29445.db.
10
Treating opioid addiction.治疗阿片类药物成瘾。
CMAJ. 2012 Sep 18;184(13):1499. doi: 10.1503/cmaj.112-2064.
引用本文的文献
1
Innovations at the intersection of homelessness and substance use during the COVID-19 pandemic: a scoping review.新冠疫情期间无家可归与药物使用交叉领域的创新：一项范围综述
Harm Reduct J. 2025 Jul 29;22(1):132. doi: 10.1186/s12954-025-01235-7.
2
Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs.按前往阿片类药物治疗项目的驾车时间划分的医疗保险受益者美沙酮接受情况。
JAMA Netw Open. 2025 Apr 1;8(4):e253099. doi: 10.1001/jamanetworkopen.2025.3099.
3
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset.美国阿片类药物治疗项目中个体在新冠疫情爆发前后每日美沙酮配药轨迹的状态序列分析
Addiction. 2025 Jun;120(6):1207-1222. doi: 10.1111/add.70008. Epub 2025 Feb 26.
4
The impact of buprenorphine prescriber data on geospatial access to treatment in HEALing Communities Study communities, 2022.丁丙诺啡处方医生数据对2022年HEALing Communities Study社区治疗地理空间可及性的影响
J Subst Use Addict Treat. 2025 Apr;171:209625. doi: 10.1016/j.josat.2025.209625. Epub 2025 Jan 27.
5
Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic.新泽西州医疗补助受益人的美沙酮治疗利用情况和 COVID-19 大流行前后的过量用药趋势。
J Subst Use Addict Treat. 2024 Dec;167:209476. doi: 10.1016/j.josat.2024.209476. Epub 2024 Aug 7.
6
Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.在假设情况下，治疗阿片类药物使用障碍的美沙酮供应不足，突显了获得药物治疗的空间不平等。
PLoS Comput Biol. 2024 Jul 26;20(7):e1012307. doi: 10.1371/journal.pcbi.1012307. eCollection 2024 Jul.
7
Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities.社区心理健康机构中阿片类药物使用障碍药物的供应情况。
JAMA Netw Open. 2024 Jun 3;7(6):e2417545. doi: 10.1001/jamanetworkopen.2024.17545.
8
Racial and Ethnic Disparities in Geographic Availability of Buprenorphine.阿片类药物丁丙诺啡的地理可及性存在种族和民族差异。
J Addict Med. 2024;18(3):335-338. doi: 10.1097/ADM.0000000000001287.
9
US payment policy for medications to treat opioid use disorder: landscape and opportunities.美国治疗阿片类药物使用障碍药物的支付政策：现状与机遇
Health Aff Sch. 2024 Feb 27;2(3):qxae024. doi: 10.1093/haschl/qxae024. eCollection 2024 Mar.
10
Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.运用药物经济学研究为阿片类药物使用障碍提供循证医学信息。
Expert Rev Pharmacoecon Outcomes Res. 2024 Jun;24(5):599-611. doi: 10.1080/14737167.2024.2350561. Epub 2024 May 9.
本文引用的文献
1
Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US.美国到达阿片类药物治疗项目和药店的驾驶时间比较。
JAMA Psychiatry. 2020 Nov 1;77(11):1163-1171. doi: 10.1001/jamapsychiatry.2020.1624.
2
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.美国五个州基于药房的美沙酮配药及前往美沙酮治疗机构的驾车时长：一项横断面研究。
Drug Alcohol Depend. 2020 Mar 27;211:107968. doi: 10.1016/j.drugalcdep.2020.107968.
3
A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.对美国农村地区阿片类药物使用障碍药物治疗的特定障碍进行的系统评价。
Am J Drug Alcohol Abuse. 2020 May 3;46(3):273-288. doi: 10.1080/00952990.2019.1694536. Epub 2019 Dec 6.
4
Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States.5 个美国州城乡县的阿片类药物治疗项目行车时间。
JAMA. 2019 Oct 1;322(13):1310-1312. doi: 10.1001/jama.2019.12562.
5
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction.美沙酮至关重要：美国可从全球治疗阿片类药物成瘾工作中学到什么。
J Gen Intern Med. 2019 Jun;34(6):1039-1042. doi: 10.1007/s11606-018-4801-3. Epub 2019 Feb 6.
6
Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington.在华盛顿州斯波坎县，距离增加与阿片类药物治疗计划的每日出勤率降低有关。
J Subst Abuse Treat. 2018 Oct;93:26-30. doi: 10.1016/j.jsat.2018.07.006. Epub 2018 Jul 24.
7
Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment.基层医疗中的美沙酮——对国会来说是一小步，对成瘾治疗来说是一大步。
N Engl J Med. 2018 Jul 5;379(1):7-8. doi: 10.1056/NEJMp1803982.
Zotero 插件